Report cover image

Global Hemorrhoid Cream and Injector Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 117 Pages
SKU # APRC20339875

Description

Summary

According to APO Research, The global Hemorrhoid Cream and Injector market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Hemorrhoid Cream and Injector is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Hemorrhoid Cream and Injector include Yunnan Baiyao Group, Xiuzheng Pharmaceutical Group, Takeda Pharmaceutical, Mayinglong Pharmaceutical Group, Tucks, Sun Pharma, Prestige Consumer Healthcare, Naticura and Medline Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemorrhoid Cream and Injector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemorrhoid Cream and Injector.

The Hemorrhoid Cream and Injector market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemorrhoid Cream and Injector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Hemorrhoid Cream and Injector Segment by Company

Yunnan Baiyao Group
Xiuzheng Pharmaceutical Group
Takeda Pharmaceutical
Mayinglong Pharmaceutical Group
Tucks
Sun Pharma
Prestige Consumer Healthcare
Naticura
Medline Industries
Ferndale Healthcare
eXroid
Doctor Bulter’s
Church and Dwight
Bausch Health
AdvaCare Pharma
Hemorrhoid Cream and Injector Segment by Type

Prescription Drug
Over-The-Counter Drug
Hemorrhoid Cream and Injector Segment by Application

Hospital
Household Use
Others
Hemorrhoid Cream and Injector Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemorrhoid Cream and Injector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemorrhoid Cream and Injector and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemorrhoid Cream and Injector.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemorrhoid Cream and Injector manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Hemorrhoid Cream and Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

117 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Hemorrhoid Cream and Injector Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Hemorrhoid Cream and Injector Sales Estimates and Forecasts (2020-2031)
1.3 Hemorrhoid Cream and Injector Market by Type
1.3.1 Prescription Drug
1.3.2 Over-The-Counter Drug
1.4 Global Hemorrhoid Cream and Injector Market Size by Type
1.4.1 Global Hemorrhoid Cream and Injector Market Size Overview by Type (2020-2031)
1.4.2 Global Hemorrhoid Cream and Injector Historic Market Size Review by Type (2020-2025)
1.4.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Hemorrhoid Cream and Injector Sales Breakdown by Type (2020-2025)
1.5.2 Europe Hemorrhoid Cream and Injector Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Breakdown by Type (2020-2025)
1.5.4 South America Hemorrhoid Cream and Injector Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Hemorrhoid Cream and Injector Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Hemorrhoid Cream and Injector Industry Trends
2.2 Hemorrhoid Cream and Injector Industry Drivers
2.3 Hemorrhoid Cream and Injector Industry Opportunities and Challenges
2.4 Hemorrhoid Cream and Injector Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Hemorrhoid Cream and Injector Revenue (2020-2025)
3.2 Global Top Players by Hemorrhoid Cream and Injector Sales (2020-2025)
3.3 Global Top Players by Hemorrhoid Cream and Injector Price (2020-2025)
3.4 Global Hemorrhoid Cream and Injector Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Hemorrhoid Cream and Injector Major Company Production Sites & Headquarters
3.6 Global Hemorrhoid Cream and Injector Company, Product Type & Application
3.7 Global Hemorrhoid Cream and Injector Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Hemorrhoid Cream and Injector Market CR5 and HHI
3.8.2 Global Top 5 and 10 Hemorrhoid Cream and Injector Players Market Share by Revenue in 2024
3.8.3 2023 Hemorrhoid Cream and Injector Tier 1, Tier 2, and Tier 3
4 Hemorrhoid Cream and Injector Regional Status and Outlook
4.1 Global Hemorrhoid Cream and Injector Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Hemorrhoid Cream and Injector Historic Market Size by Region
4.2.1 Global Hemorrhoid Cream and Injector Sales in Volume by Region (2020-2025)
4.2.2 Global Hemorrhoid Cream and Injector Sales in Value by Region (2020-2025)
4.2.3 Global Hemorrhoid Cream and Injector Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Region
4.3.1 Global Hemorrhoid Cream and Injector Sales in Volume by Region (2026-2031)
4.3.2 Global Hemorrhoid Cream and Injector Sales in Value by Region (2026-2031)
4.3.3 Global Hemorrhoid Cream and Injector Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Hemorrhoid Cream and Injector by Application
5.1 Hemorrhoid Cream and Injector Market by Application
5.1.1 Hospital
5.1.2 Household Use
5.1.3 Others
5.2 Global Hemorrhoid Cream and Injector Market Size by Application
5.2.1 Global Hemorrhoid Cream and Injector Market Size Overview by Application (2020-2031)
5.2.2 Global Hemorrhoid Cream and Injector Historic Market Size Review by Application (2020-2025)
5.2.3 Global Hemorrhoid Cream and Injector Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Hemorrhoid Cream and Injector Sales Breakdown by Application (2020-2025)
5.3.2 Europe Hemorrhoid Cream and Injector Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Breakdown by Application (2020-2025)
5.3.4 South America Hemorrhoid Cream and Injector Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Hemorrhoid Cream and Injector Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Yunnan Baiyao Group
6.1.1 Yunnan Baiyao Group Comapny Information
6.1.2 Yunnan Baiyao Group Business Overview
6.1.3 Yunnan Baiyao Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Yunnan Baiyao Group Hemorrhoid Cream and Injector Product Portfolio
6.1.5 Yunnan Baiyao Group Recent Developments
6.2 Xiuzheng Pharmaceutical Group
6.2.1 Xiuzheng Pharmaceutical Group Comapny Information
6.2.2 Xiuzheng Pharmaceutical Group Business Overview
6.2.3 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Xiuzheng Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
6.2.5 Xiuzheng Pharmaceutical Group Recent Developments
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Comapny Information
6.3.2 Takeda Pharmaceutical Business Overview
6.3.3 Takeda Pharmaceutical Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceutical Hemorrhoid Cream and Injector Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments
6.4 Mayinglong Pharmaceutical Group
6.4.1 Mayinglong Pharmaceutical Group Comapny Information
6.4.2 Mayinglong Pharmaceutical Group Business Overview
6.4.3 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mayinglong Pharmaceutical Group Hemorrhoid Cream and Injector Product Portfolio
6.4.5 Mayinglong Pharmaceutical Group Recent Developments
6.5 Tucks
6.5.1 Tucks Comapny Information
6.5.2 Tucks Business Overview
6.5.3 Tucks Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tucks Hemorrhoid Cream and Injector Product Portfolio
6.5.5 Tucks Recent Developments
6.6 Sun Pharma
6.6.1 Sun Pharma Comapny Information
6.6.2 Sun Pharma Business Overview
6.6.3 Sun Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sun Pharma Hemorrhoid Cream and Injector Product Portfolio
6.6.5 Sun Pharma Recent Developments
6.7 Prestige Consumer Healthcare
6.7.1 Prestige Consumer Healthcare Comapny Information
6.7.2 Prestige Consumer Healthcare Business Overview
6.7.3 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Prestige Consumer Healthcare Hemorrhoid Cream and Injector Product Portfolio
6.7.5 Prestige Consumer Healthcare Recent Developments
6.8 Naticura
6.8.1 Naticura Comapny Information
6.8.2 Naticura Business Overview
6.8.3 Naticura Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Naticura Hemorrhoid Cream and Injector Product Portfolio
6.8.5 Naticura Recent Developments
6.9 Medline Industries
6.9.1 Medline Industries Comapny Information
6.9.2 Medline Industries Business Overview
6.9.3 Medline Industries Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medline Industries Hemorrhoid Cream and Injector Product Portfolio
6.9.5 Medline Industries Recent Developments
6.10 Ferndale Healthcare
6.10.1 Ferndale Healthcare Comapny Information
6.10.2 Ferndale Healthcare Business Overview
6.10.3 Ferndale Healthcare Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ferndale Healthcare Hemorrhoid Cream and Injector Product Portfolio
6.10.5 Ferndale Healthcare Recent Developments
6.11 eXroid
6.11.1 eXroid Comapny Information
6.11.2 eXroid Business Overview
6.11.3 eXroid Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.11.4 eXroid Hemorrhoid Cream and Injector Product Portfolio
6.11.5 eXroid Recent Developments
6.12 Doctor Bulter’s
6.12.1 Doctor Bulter’s Comapny Information
6.12.2 Doctor Bulter’s Business Overview
6.12.3 Doctor Bulter’s Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Doctor Bulter’s Hemorrhoid Cream and Injector Product Portfolio
6.12.5 Doctor Bulter’s Recent Developments
6.13 Church and Dwight
6.13.1 Church and Dwight Comapny Information
6.13.2 Church and Dwight Business Overview
6.13.3 Church and Dwight Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Church and Dwight Hemorrhoid Cream and Injector Product Portfolio
6.13.5 Church and Dwight Recent Developments
6.14 Bausch Health
6.14.1 Bausch Health Comapny Information
6.14.2 Bausch Health Business Overview
6.14.3 Bausch Health Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bausch Health Hemorrhoid Cream and Injector Product Portfolio
6.14.5 Bausch Health Recent Developments
6.15 AdvaCare Pharma
6.15.1 AdvaCare Pharma Comapny Information
6.15.2 AdvaCare Pharma Business Overview
6.15.3 AdvaCare Pharma Hemorrhoid Cream and Injector Sales, Revenue and Gross Margin (2020-2025)
6.15.4 AdvaCare Pharma Hemorrhoid Cream and Injector Product Portfolio
6.15.5 AdvaCare Pharma Recent Developments
7 North America by Country
7.1 North America Hemorrhoid Cream and Injector Sales by Country
7.1.1 North America Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Hemorrhoid Cream and Injector Sales by Country (2020-2025)
7.1.3 North America Hemorrhoid Cream and Injector Sales Forecast by Country (2026-2031)
7.2 North America Hemorrhoid Cream and Injector Market Size by Country
7.2.1 North America Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Hemorrhoid Cream and Injector Market Size by Country (2020-2025)
7.2.3 North America Hemorrhoid Cream and Injector Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Hemorrhoid Cream and Injector Sales by Country
8.1.1 Europe Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Hemorrhoid Cream and Injector Sales by Country (2020-2025)
8.1.3 Europe Hemorrhoid Cream and Injector Sales Forecast by Country (2026-2031)
8.2 Europe Hemorrhoid Cream and Injector Market Size by Country
8.2.1 Europe Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Hemorrhoid Cream and Injector Market Size by Country (2020-2025)
8.2.3 Europe Hemorrhoid Cream and Injector Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Hemorrhoid Cream and Injector Sales by Country
9.1.1 Asia-Pacific Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Hemorrhoid Cream and Injector Sales by Country (2020-2025)
9.1.3 Asia-Pacific Hemorrhoid Cream and Injector Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Hemorrhoid Cream and Injector Market Size by Country
9.2.1 Asia-Pacific Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Hemorrhoid Cream and Injector Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Hemorrhoid Cream and Injector Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Hemorrhoid Cream and Injector Sales by Country
10.1.1 South America Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Hemorrhoid Cream and Injector Sales by Country (2020-2025)
10.1.3 South America Hemorrhoid Cream and Injector Sales Forecast by Country (2026-2031)
10.2 South America Hemorrhoid Cream and Injector Market Size by Country
10.2.1 South America Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Hemorrhoid Cream and Injector Market Size by Country (2020-2025)
10.2.3 South America Hemorrhoid Cream and Injector Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Hemorrhoid Cream and Injector Sales by Country
11.1.1 Middle East and Africa Hemorrhoid Cream and Injector Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Hemorrhoid Cream and Injector Sales by Country (2020-2025)
11.1.3 Middle East and Africa Hemorrhoid Cream and Injector Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Hemorrhoid Cream and Injector Market Size by Country
11.2.1 Middle East and Africa Hemorrhoid Cream and Injector Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Hemorrhoid Cream and Injector Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Hemorrhoid Cream and Injector Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Hemorrhoid Cream and Injector Value Chain Analysis
12.1.1 Hemorrhoid Cream and Injector Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Hemorrhoid Cream and Injector Production Mode & Process
12.2 Hemorrhoid Cream and Injector Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Hemorrhoid Cream and Injector Distributors
12.2.3 Hemorrhoid Cream and Injector Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.